Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Average Recommendation of "Buy" from Analysts

Retrieved on: 2021-04-17 02:15:00

Tags for this article:

Click the tags to see associated articles and topics

Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Average Recommendation of "Buy" from Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 1,407,348 shares of the company's stock valued at $84,441,000 after purchasing an additional 210,428 shares in the last ...

Article found on: www.marketbeat.com